The NKI is the only dedicated comprehensive cancer center in the Netherlands. Collaboration is of vital importance to us for tackling cancer within the Netherlands and beyond and to optimize our value for cancer patients. This is why we actively reach out and form networks and partnerships with a whole range of academic, public and private organizations in the Netherlands.
The NKI is an independent comprehensive cancer center with close ties to the Dutch universities and their academic hospitals. We hold 57 dedicated university chairs and currently host around 300 PhD students. All students have their own research project, which they work on to obtain a PhD degree. The NKI also offers master and bachelor students the possibility to undertake an internship research project in our research institute.
Amsterdam aims to become one of the world’s premier locations for research and development on AI. Under the name Amsterdam AI', leading knowledge institutes and the City of Amsterdam are working together closely to make the best possible use of AI expertise.
In 2012 the NKI, together with the University Medical Center Utrecht and the Erasmus Medical Center in Rotterdam, initiated the Center for Personalized Medicine (CPCT), an alliance that combines efforts in cancer genomics. This consortium now encompasses more than 45 hospitals in the Netherlands, including all academic hospitals.
COIN stands for ‘Circulating tumor DNA On the road to Implementation in the Netherlands'. In a collaboration that has no equivalent in any other country, the NKI, all academic hospitals in the Netherlands, and many other public and private organizations, have joined forces to study how ctDNA diagnostics can be implemented into the Dutch health system in a standardized way.
Read more (in Dutch)
The NKI collaborates closely with Hartwig Medical Foundation (HMF). HMF was founded in 2015 by the CPCT with the aim of professionalizing and centralizing whole genome sequencing and analysis. This resulted in the first national database with genetic and clinical data of patients suffering from metastatic cancer. In 2019, HMF and the NKI initiated the WIDE study, to asses the feasibility of implementing whole genome sequencing in standard of care cancer diagnostics.
Health-RI is the Dutch non-profit foundation supporting a public-private partnership of more than 70 organizations that want to realize a national health-data infrastructure. Its mission is to build an integrated health data research infrastructure accessible for researchers, citizens and care providers and to accelerate sustainable and affordable personalized medicine and health.
In 2020, the University of Amsterdam (UvA) and the Netherlands Cancer Institute have joined forces in the development of AI algorithms that can improve cancer treatment. The collaboration combines expertise in cancer research with that in AI techniques. The lab will be part of the Innovation Center for Artificial Intelligence (ICAI).
Through the Oncology Graduate School Amsterdam (OOA), the NKI, the Amsterdam UMC, the University of Amsterdam and Vrije Universiteit Amsterdam offer a joint a joint educational program for PhD students.
PALGA is the nationwide network and registry of histopathology and cytopathology in the Netherlands. PALGA, which is unique in the world, aims at promoting collaboration between pathology laboratories and making new knowledge available to health care. The PALGA data form the basis for the national cancer registry.
SHA was founded by the City of Amsterdam, the Amsterdam Economic Board and Amsterdam&partners to offer a strong network for data- and AI-driven innovation in Amsterdam’s life sciences and health sector. SHA connects all data and AI-related key players, institutions, innovators, scientists, medics, investors and other bright minds of Amsterdam.
